SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-122540
Filing Date
2020-11-06
Accepted
2020-11-06 16:31:46
Documents
14
Period of Report
2020-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2035156-1_8k.htm   iXBRL 8-K 25670
2 EXHIBIT 99.1 tm2035156d1_ex99-1.htm EX-99.1 87152
6 GRAPHIC image_001.jpg GRAPHIC 15494
  Complete submission text file 0001104659-20-122540.txt   318002

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbio-20201106.xsd EX-101.SCH 3192
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20201106_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20201106_pre.xml EX-101.PRE 22714
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2035156-1_8k_htm.xml XML 3600
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 201294898
SIC: 2834 Pharmaceutical Preparations